IN HB1146

Requires only physicians licensed in Indiana to administer abortion-inducing drugs, and they must follow FDA-approved drug label protocols

Physicians must examine the pregnant woman in person, document fetal gestational age and intrauterine location, and provide the drug label and emergency contact information before administering the drug

Mandates a follow-up appointment approximately 14 days after administration to confirm pregnancy termination via ultrasound and assess bleeding

Physicians must contract with another licensed physician who has hospital admitting, gynecological, and surgical privileges to handle potential complications

Requires physicians to report any adverse events (death, hospitalization, disability, birth defects, or life-threatening occurrences) to the FDA and Indiana Medical Licensing Board within 3 days; violations constitute a Class A misdemeanor